Abella, Jose R.

HRN: 27-08-02  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2025
CEFTRIAXONE 1G (VIAL)
05/03/2025
05/09/2025
IV
2g
OD
T/c Acute Pyelonephritis; R/o Septic Arthritis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary TractBone & Joint    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: